Patterns of use of targeted temperature management for acute myocardial infarction patients following out-of-hospital cardiac arrest: Insights from the National Cardiovascular Data Registry - 12/12/18
Doi : 10.1016/j.ahj.2018.08.013
Christopher B. Fordyce a, ⁎ 
, Anita Y. Chen b, Tracy Y. Wang b, Joseph Lucas b, Abhinav Goyal c, Graham C. Wong a, Sean van Diepen d, Michael C. Kontos e, Timothy D. Henry f, Christopher B. Granger b, Matthew T. Roe b
, Anita Y. Chen b, Tracy Y. Wang b, Joseph Lucas b, Abhinav Goyal c, Graham C. Wong a, Sean van Diepen d, Michael C. Kontos e, Timothy D. Henry f, Christopher B. Granger b, Matthew T. Roe b a Division of Cardiology, University of British Columbia, Vancouver, BC, Canada
b Duke Clinical Research Institute, Durham, NC
c Department of Medicine, Emory University School of Medicine, Atlanta, GA
d Department of Critical Care and Division of Cardiology, University of Alberta, Edmonton, AB, Canada
e Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA
f Cedars-Sinai Heart Institute, Los Angeles, CA
⁎Reprint requests: Christopher B. Fordyce, MD, MHS, MSc, Division of Cardiology, University of British Columbia, 2775 Laurel St – 9th Floor, Vancouver, BC, V5Z 1M9.Division of CardiologyUniversity of British Columbia2775 Laurel St – 9th FloorVancouverBCV5Z 1M9
Abstract |
Contemporary utilization patterns for targeted temperature management (TTM) among patients with acute myocardial infarction (MI) and out-of-hospital cardiac arrest (OHCA) have not been well characterized in the United States. In this nationwide evaluation of MI patients with OHCA (01/2015–03/2016; 691 hospitals), 34.1% (1792/5260) of OHCA patients received TTM. Patients who were treated with TTM had higher risk clinical features. A wide inter-hospital variation (ranging from 0% to 82%) in TTM use observed despite few differences in case mix.
Le texte complet de cet article est disponible en PDF.Plan
© 2018
Elsevier Inc. Tous droits réservés.
Vol 206
P. 131-133 - décembre 2018 Retour au numéro
Article précédent
- Randomized trial of rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis
- Juhwan Lee, Rine Nakanishi, Dong Li, Kashif Shaikh, Chandana Shekar, Kazuhiro Osawa, Negin Nezarat, Eranthi Jayawardena, Maja Blanco, Matthew Chen, Matthew Sieckert, Eric Nelson, Darius Billingsley, Sajad Hamal, Matthew J. Budoff
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?